Revolution Medicines (RVMD) Prepaid Assets (2019 - 2026)

Revolution Medicines' (RVMD) quarterly Prepaid Assets came in at $59.8 million in Q1 2026, up 87.51% year-on-year from $31.9 million in Q1 2025, and up 21.21% quarter-over-quarter from $49.4 million in Q4 2025.

Revolution Medicines (RVMD) Prepaid Assets (2019 - 2026) Analysis & Trends

Revolution Medicines' Prepaid Assets history runs 8 years deep, the most recent figure standing at $59.8 million for Q1 2026.

  • On a quarterly basis, Prepaid Assets rose 87.51% year-over-year to $59.8 million in Q1 2026; TTM through Mar 2026 was $59.8 million, a 87.51% increase from a year earlier, with the FY2025 full-year figure at $49.4 million, up 28.76% from the prior year.
  • Prepaid Assets climbed to $59.8 million in Q1 2026 per RVMD's latest filing, from $49.4 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $59.8 million in Q1 2026 and bottomed at $9.0 million in Q1 2023.
  • The 5-year median for Prepaid Assets is $25.7 million (2024), against an average of $27.1 million.
  • Across the five-year window, Prepaid Assets sank 36.88% in 2023 and jumped 237.02% in 2024, its largest moves.
  • Year by year, Prepaid Assets stood at $10.6 million in 2022, then jumped by 137.22% to $25.1 million in 2023, then soared by 52.89% to $38.3 million in 2024, then climbed by 28.76% to $49.4 million in 2025, then advanced by 21.21% to $59.8 million in 2026.
  • Per Business Quant, the three latest RVMD Prepaid Assets figures stand at $59.8 million (Q1 2026), $49.4 million (Q4 2025), and $46.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 59.83 Mn
Dec 31, 2025 49.36 Mn
Sep 30, 2025 45.98 Mn
Jun 30, 2025 39.27 Mn
Mar 31, 2025 31.91 Mn
Dec 31, 2024 38.33 Mn
Sep 30, 2024 29.66 Mn
Jun 30, 2024 34.02 Mn
Mar 31, 2024 25.66 Mn
Dec 31, 2023 25.07 Mn
Sep 30, 2023 10.96 Mn
Jun 30, 2023 10.09 Mn
Mar 31, 2023 8.96 Mn
Dec 31, 2022 10.57 Mn
Sep 30, 2022 15.16 Mn
Jun 30, 2022 15.99 Mn
Mar 31, 2022 10.21 Mn
Dec 31, 2021 6.79 Mn
Sep 30, 2021 7.47 Mn
Jun 30, 2021 8.16 Mn